Sanara Medtech
Yahoo Finance • 11 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newacti... Full story
Yahoo Finance • 19 days ago
Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook
Earnings Call Insights: Sanara MedTech (SMTI) Q1 2026 MANAGEMENT VIEW * “This was a strong quarter for us, which exceeded our expectations.” (President, CEO & Director Seth Yon) Yon said Q1 2026 was “the first full quarter in which we... Full story
Yahoo Finance • 19 days ago
Sanara Swings To Profit In Q1; Stock Up
(RTTNews) - Sanara MedTech Inc. (SMTI), a medical technology company, on Monday released its first quarter financial results. The company specializes in the development and commercialization of technologies that improve clinical outcomes... Full story
Yahoo Finance • 19 days ago
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,”... Full story
Yahoo Finance • 23 days ago
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ... Full story
Yahoo Finance • 26 days ago
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript
Image source: The Motley Fool. DATE Tuesday, March 24, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Seth Yon Chief Financial Officer — Elizabeth Taylor Full Conference Call Transcript Seth Yon: Thanks, operator, and... Full story
Yahoo Finance • last month
What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?
White Brook Capital Partners, an investment management firm, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter indicated that the first quarter of 2026 was a turnaround period. During... Full story
Yahoo Finance • 2 months ago
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
FORT WORTH, TX, April 14, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company”, “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to i... Full story
Yahoo Finance • 2 months ago
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sanara MedTech, Inc., (“Sanara" or the "Company") (NASDAQ:SMTI) investors that the firm has initiated an investigation into possible securities fraud, and may f... Full story
Yahoo Finance • 2 months ago
Sanara MedTech Q4 Earnings Call Highlights
Sanara MedTech logo Sanara MedTech (NASDAQ:SMTI) reported fourth-quarter and full-year 2025 results highlighting record annual revenue, improved profitability, and progress in its transition to a “pure-play” surgical company following the... Full story
Yahoo Finance • 6 months ago
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
ATLANTA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI) complied with federal securities laws. On November 11, 2025, Sanara announced that “t... Full story
Yahoo Finance • 6 months ago
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to im... Full story
Yahoo Finance • 7 months ago
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus
Earnings Call Insights: Sanara MedTech Inc. (SMTI) Q3 2025 MANAGEMENT VIEW * Seth Yon, President and CEO, opened with, "As the recently appointed President and CEO, I'll begin with a brief introduction and provide some opening thoughts... Full story
Yahoo Finance • 7 months ago
3 Growth Companies With Insider Ownership Up To 31%
As major stock indexes in the United States continue to reach new heights, driven by significant developments such as Nvidia's landmark $5 trillion market cap and anticipation around Federal Reserve decisions, investors are keenly watching... Full story
Yahoo Finance • 9 months ago
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SM... Full story
Yahoo Finance • 9 months ago
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to im... Full story
Yahoo Finance • 10 months ago
Sanara MedTech outlines $5.5M–$6.5M THP investment target while advancing surgical segment growth
Earnings Call Insights: Sanara MedTech Inc. (SMTI) Q2 2025 MANAGEMENT VIEW * Ronald T. Nixon, Executive Chairman and CEO, opened the call by highlighting "net revenue of $25.8 million in the second quarter, representing 28% growth year... Full story
Yahoo Finance • 10 months ago
Sanara Medtech earnings beat by $0.26, revenue topped estimates
Investing.com - Sanara Medtech (NASDAQ: SMTI) reported second quarter EPS of $-0.23, $0.26 better than the analyst estimate of $-0.49. Revenue for the quarter came in at $25.83M versus the consensus estimate of $25.15M. Sanara Medtech’s s... Full story
Yahoo Finance • 10 months ago
Earnings call transcript: Sanara MedTech sees revenue surge in Q2 2025
Sanara MedTech Inc. (SMTI) reported a strong second quarter for 2025, with significant growth in revenue and improved net income. The company achieved a net revenue of $25.8 million, reflecting a 28% year-over-year increase, maintaining it... Full story
Yahoo Finance • 10 months ago
Sanara MedTech Inc (NASDAQ:SMTI) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss, Shares Surge 8.4%
Sanara MedTech Inc (NASDAQ:SMTI [https://www.chartmill.com/stock/quote/SMTI]) reported its second-quarter 2025 financial results, revealing a mixed performance relative to analyst expectations. The company’s revenue growth outpaced estimat... Full story